Diabetes Care February 2023 PMID 36356111

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.

Julien Bezin, Amandine Gouverneur, Marine Pénichon, Clément Mathieu, Renaud Garrel, Dominique Hillaire-Buys, Antoine Pariente, Jean-Luc Faillie

Mentions

282
Peak: 49 in Dec 2022
across 7 sources since Nov 2022

Extended reach

1,015,170
potential audience

Total likes

632

Video views

1,763

Mentions per month

Nov 2022 – Aug 2025

Where it's discussed

  • X / Twitter190 posts
  • News75 articles
  • Blogs6 articles
  • Facebook4 posts
  • Bluesky3 posts
  • YouTube2 videos
  • Reddit2 posts

AI synopsis

What people are saying

Contributors generally emphasize the findings of the study, referencing phrases like '58% increased risk of all thyroid cancers' and '78% increased risk of medullary thyroid cancer' to illustrate their concerns. The tone of the discussions is a mix of alarm and curiosity, as seen in comments urging readers to consult medical professionals before starting GLP-1 RA medications. The choice of words such as 'must consider' and 'increased risk' conveys a sense of urgency and importance regarding the topic.

AgreementStrong agreement

The majority of discussions demonstrate strong support for the findings and the concerns raised in the publication about thyroid cancer risks linked to GLP-1 receptor agonists.

InterestHigh interest

There is evident enthusiasm and curiosity among contributors regarding the implications of the research, as many express the need for further details and clarification.

EngagementModerate engagement

While many discussions touch on the publication's details, few delve deeply into the broader implications or personal experiences, indicating moderate engagement.

ImpactHigh impact

Many participants perceive the research as significantly impactful, highlighting its relevance to public health and medical practice.

Abstract in brief

  • This study investigates whether GLP1 receptor agonists (RA) increase the risk of thyroid cancer in patients with type 2 diabetes.
  • The analysis used data from the French national health care system, comparing 2562 thyroid cancer patients to 45184 controls matched by age, sex, and diabetes duration.
  • Results indicated a higher risk of thyroid cancer overall, and specifically medullary thyroid cancer, linked to 13 years of GLP1 RA treatment.

Top posts

Most liked on X and Bluesky
endocrinorosero
@endocrinorosero · X

Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 224 likes · 39 shares · 160,102 followers View post →
Giuseppe Maltese
@docmaltese · X

GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhmal https://t.co/73VNByrOLY https://t.co/Ngb6ObhcS5

Dec 27, 2022 · 103 likes · 33 shares · 1,787 followers View post →
Dr. Ilin Gilberto de la Torre M.
@IlindelatorreMD · X

Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 46 likes · 17 shares · 45,732 followers View post →
Diabetes Care, a research journal of the ADA
@DiabetesCareADA · X

A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased risk of thyroid cancer. #Pharmacoepi @DrugsSafe Read Here➡️https://t.co/s0PAaHPbq5 https://t.co/JOOd98Yo8i

Nov 24, 2022 · 39 likes · 17 shares · 3,191 followers View post →
Peter Mantas
@peter_mantas · X

New study is pretty clear: “In the current study we found increased risk of all thyroid cancer and medullary thyroid cancer with use of GLP-1 RA, in particular after 1-3 years of treatment.” $NVO $LLY https://t.co/CnDZcEhtGD

Oct 24, 2023 · 33 likes · 2 shares · 6,410 followers View post →
Royal College of Anaesthetists
@rcoanews.bsky.social · Bluesky

NEW: drug safety update on GLP-1 and dual GIP/GLP-1 receptor agonists and the risk of pulmonary aspiration during anaesthesia or deep sedation. The MHRA emphasises individualised risk assessment and asking patients directly about these medications: ow.ly/Rl1x50UQ5xu

Jan 30, 2025 · 11 likes · 12 shares View post →

All mentions

Yaffa Shir-Raz
@YaffaRaz · X

https://t.co/Yy2C0WYIRT

Aug 22, 2025 · 4 likes · 16,235 followers View post →
Lily
@Lily4Lily2 · X

C-celtumoren komen voor in de schildklier bij blootstelling aan GLP-1-receptoragonisten. Hogere percentages schildklierkanker bij mensen die semaglutide gebruikten, vooral na 1 tot 3 jaar gebruik. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/1W5n94xoWD https://t.co/6agdzTj2Nc

Aug 22, 2025 · 656 followers View post →
Mon Module 5
@module5 · X

RT @Fraslin: Une vaste étude française a observé une augmentation du risque de cancer de la thyroïde, notamment sous sa forme médullaire, c…

Aug 14, 2025 · 1 share · 2,389 followers View post →
Dr Jean-Jacques Fraslin
@Fraslin · X

Une vaste étude française a observé une augmentation du risque de cancer de la thyroïde, notamment sous sa forme médullaire, chez les utilisateurs de GLP-1 pendant un à trois ans. Les chercheurs ont également constaté que ce risque restait légèrement https://t.co/krboiZe4el

Aug 14, 2025 · 7 likes · 1 share · 30,279 followers View post →
Marion Holman
@Marion436842126 · X

@jenstaffeldt @Mangan150 oxidative stress and monocyte-driven inflammation. Exercise directly lowers cytokines like IL-6 and TNF-α via anti-inflammatory pathways. Did your doctor mention the increased risk of thyroid cancer using GLP1’s ? https://t.co/FGHHBxWRxR

Jun 30, 2025 · 1 like · 19,406 followers View post →
From the Start Nutrition
@fromthestartrdn · X

@Stumpeed @upRootNutrition There is always risk. Risk is not a bad thing, it is a part of life. Risk is a thing to monitor, evaluate, and adjust as needed. Case in point: https://t.co/U4R7Eb4ICf

May 1, 2025 · 189 followers View post →
Neil Floch MD FACS FASMBS DABOM
@neilflochmd.bsky.social · Bluesky

GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study - Surgery for Obesity and Related Diseases www.soard.org/article/S155...

Apr 23, 2025 View post →
AllCEUs Counselor Education with Dawn-Elise Snipes
@AllCEUs · X

Glp1 agonists associated with increased risk of all types of thyroid cancer https://t.co/dvfDCthNqW @MakisMD @RobertKennedyJr

Mar 13, 2025 · 1,692 followers View post →
GirlScout27
@GirlScout27 · X

@john_ford77 @DalgetySusan https://t.co/WJDOBijykX

Feb 24, 2025 · 1,587 followers View post →
Royal College of Anaesthetists
@rcoanews.bsky.social · Bluesky

NEW: drug safety update on GLP-1 and dual GIP/GLP-1 receptor agonists and the risk of pulmonary aspiration during anaesthesia or deep sedation. The MHRA emphasises individualised risk assessment and asking patients directly about these medications: ow.ly/Rl1x50UQ5xu

Jan 30, 2025 · 11 likes · 12 shares View post →
American Eagle
@austin_micc130 · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer | Diabetes Care | American Diabetes Association https://t.co/cjG2k5XN1F

Jan 28, 2025 · 336 followers View post →
D.Aldo
@Daldo67 · X

@CollinRugg Risk of all thyroid cancers with use of Glp-1 medications. https://t.co/vGu6ev2giN

Dec 29, 2024 · 920 followers View post →
The Healthy Pitmaster
@therealjimbbq · X

@DrNadolsky They aren’t as amazing as you claim them to be: A published study in Diabetes Care revealed a 58% increased risk of all thyroid cancers and a 78% increased risk of medullary thyroid cancer in users of GLP-1 receptor agonists over 1-3 years. https://t.co/gYg56GaPcM 5.1% (1 in

Dec 9, 2024 · 1 like · 127 followers View post →
inorii yuzuriha (uma autofagi)
@inorii_yuzuriha · X

RT @hanan052020: @inorii_yuzuriha https://t.co/Uq6UnKjT1K https://t.co/3swKNuKA7Y

Dec 4, 2024 · 1 share · 3,238 followers View post →
Abu Hanan
@hanan052020 · X

@inorii_yuzuriha https://t.co/Uq6UnKjT1K https://t.co/3swKNuKA7Y

Dec 4, 2024 · 1 like · 1 share · 1,201 followers View post →
turoki.bsky.social
@turoki.bsky.social · Bluesky

Ozempic is a GLP-1 like Receptor Agonists and scientist have found a link between drugs with GLP-1 and Thyroid Cancer after a 1-3 year treatment. Biden is proposing Medicare to cover Ozempic for millions of Americans who are not diabetic, but simply overweight. pubmed.ncbi.nlm.nih.gov/36356111/

Dec 1, 2024 · 2 likes · 1 share View post →
Little help here?
@legler_aaron · X

@CoffeeBlackMD @AviBittMD From the article, but it's made up?

Nov 28, 2024 · 1,039 followers View post →
Brainsurfing
@Brainsurfing22 · X

@dutchyankee2 @Tellit007 @Constantin22409 @newstart_2024 https://t.co/NFji0jukQw

Nov 23, 2024 · 1,236 followers View post →
тайна на изображение судьи
@krbchnk · X

@Limeoff @MaraStrega https://t.co/AV7k0GoFE7 Но конечно же, есть тонкости — после 1-3 лет употребления (никто кроме диабетиков не колет оземпик год), и риск ничтожный, его увеличение на 60% точно так же ничтожно.

Oct 2, 2024 · 4 likes · 1,276 followers View post →
ThyroidPatient
@ThyroidPatient · X

RT @AmThyroidAssn: Read Dr. Theodora Pappa's 2023 Rosalind Franklin Society (RFS) Award in Science article for her outstanding work in @cli…

Sep 16, 2024 · 2 shares · 267 followers View post →
Graves' Disease & Thyroid Foundation
@GDATF · X

RT @AmThyroidAssn: Read Dr. Theodora Pappa's 2023 Rosalind Franklin Society (RFS) Award in Science article for her outstanding work in @cli…

Sep 16, 2024 · 2 shares · 6,138 followers View post →
American Thyroid Association
@AmThyroidAssn · X

Read Dr. Theodora Pappa's 2023 Rosalind Franklin Society (RFS) Award in Science article for her outstanding work in @clinicalthyroid: GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. https://t.co/Axs0MpFKch #thyroidcancer #ThyroidHealth @GDATF @ThyCaInc @TheEndoSociety https://t.co/XMHZidXQXu

Sep 16, 2024 · 6 likes · 2 shares · 11,341 followers View post →
Adam May
@A_May_MD · X

@bioinvestor24 Remarkably safe to be sure, but definitely not “nothing” on the safety front. Suicidal ideation and thyroid carcinoma are two potential safety events to monitor for GLP-1! https://t.co/1FDP69LttJ https://t.co/47M2S9xf3n

Aug 29, 2024 · 18,379 followers View post →
Ukpebor Abigail
@AbigailUkp56849 · X

@ymargham Relating this to endocrine cancers, GLP-1 receptor agonists have been associated with an increased risk of medullary thyroid cancers. Bezin J et. al GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care. 2023 Feb 1;46(2):384-390. doi: 10.2337/dc22-1148.

Aug 17, 2024 · 1 like · 7 followers View post →
ThyroidPatient
@ThyroidPatient · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer | Clinical Thyroidology® https://t.co/oEc7WkQPo0

Aug 15, 2024 · 267 followers View post →
Назим Гафаров
@zapolnoch · X

@animacava @Mael1Radec A total of 2,562 case subjects with thyroid cancers were included in the study and matched with 45,184 control subjects. Use of GLP-1 RA for 1–3 years was associated with increased risk of all thyroid cancer. https://t.co/lUTUzC0wFk Скорректированный коэффициент риска

Jul 26, 2024 · 2 likes · 1 share · 11,514 followers View post →
H. Turgeman
@SpinosaCapparis · X

@ArbleMatan מקור על הערכת הסיכון בבני אדם: https://t.co/tWbcwRiVfI

Jul 23, 2024 · 1 like · 6 followers View post →
Kubilay Karşıdağ
@kubilaykarsidag · X

@DeryaTR_ İskandinav çalışması dışında veriler o doğrultuda değil değil Sayın Hocam. https://t.co/QHMt135F6r

Jun 28, 2024 · 3 likes · 14,043 followers View post →
T
@Anon1917T · X

@EndoDialogues https://t.co/qPfb2uAenA just a thought

May 8, 2024 · 32 followers View post →
Marko Da Beast
@BoteekBoteek · X

@dutchyankee2 @BettyDavisEyess @DrNadolsky Humans. 2,562 case subjects with thyroid cancers matched with 45,184 control subjects. "In the current study we found increased risk of all thyroid cancer and medullary thyroid cancer with use of GLP-1 RA, in particular after 1-3 years of treatment." https://t.co/avsE3u6eY1

Apr 27, 2024 · 1,186 followers View post →
Marko Da Beast
@BoteekBoteek · X

@PhunkNemo @RyanPatrickHef1 @BioLayne Humans... - 2,562 case subjects with thyroid cancers included, matched with 45,184 control subjects. "we found increased risk of all thyroid cancer and medullary thyroid cancer with use of GLP-1 RA, in particular after 1–3 years of treatment." https://t.co/bMP2HfwaaY

Apr 4, 2024 · 1,186 followers View post →
nico
@niconi_niconi · X

@jaeholee_dev @vhender_ "glp-1 receptor agonists and the risk of thyroid cancer" 프랑스인 2500명으로 실험한 논문에서는 연관 있다고 나오는걸보니 아직 제대로 정립된건 아닌거같습니다.

Dec 28, 2023 · 3 likes · 869 followers View post →
Rodolfo J. Galindo MD
@RodolfoJGalindo · X

https://t.co/KmA9G2Rruq Including this paper, @EMA_News found no causal association

Oct 27, 2023 · 1,109 followers View post →
.
@bruin0927 · X

RT @peter_mantas: New study is pretty clear: “In the current study we found increased risk of all thyroid cancer and medullary thyroid canc…

Oct 24, 2023 · 2 shares · 178 followers View post →
Pythia Cap: Vertical Market Sycophant
@PythiaR · X

RT @peter_mantas: New study is pretty clear: “In the current study we found increased risk of all thyroid cancer and medullary thyroid canc…

Oct 24, 2023 · 2 shares · 65,188 followers View post →
Peter Mantas
@peter_mantas · X

New study is pretty clear: “In the current study we found increased risk of all thyroid cancer and medullary thyroid cancer with use of GLP-1 RA, in particular after 1-3 years of treatment.” $NVO $LLY https://t.co/CnDZcEhtGD

Oct 24, 2023 · 33 likes · 2 shares · 6,410 followers View post →
Sorrel
@sorrelmysweet · X

@bmj_latest Don't forget the increase in thyroid cancer! "In the current study we found increased risk of all thyroid cancer and medullary thyroid cancer with use of GLP-1 RA, in particular after 1–3 years of treatment." https://t.co/XQpW0Og4YF

Oct 9, 2023 · 1 like · 418 followers View post →
airbuilt
@airbuilt0 · X

@elonmusk @Walmart An important side effect to consider: https://t.co/giMetupDL7

Oct 6, 2023 · 6 followers View post →
Imtiaz
@mlimtiaz · X

Great article: GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. https://t.co/nz8v9CSYu5 #ReadByQxMD

Sep 20, 2023 · 295 followers View post →
وعـــد الحربـي
@PromiseAlharbi · X

اما هذي توتر صراحة بس مادرست Semaglutide https://t.co/dSa7quahEd

Aug 24, 2023 · 1 like · 2,737 followers View post →
Timothy
@Timomies · X

@skathire So that's way less beneficial than eating more to the direction of Mediterranean diet: https://t.co/g1ocMAYH9d without the 58%-78% increased risk of thyroid cancers: https://t.co/lUw2vdmTL8 https://t.co/BSgT4HVHbs

Aug 8, 2023 · 1 like · 126 followers View post →
JustBeingHuman
@HumanOnlyBeing · X

@JustJewels93 Here's some more info. I'd usually. EVER share anything ADA bc they're a horrible org IMO BUT I did find this summary: https://t.co/AZ2sdL3O4G

Jul 25, 2023 · 1 like · 607 followers View post →
C 
@AsfyXi · X

Bezin J, Gouverneur A, Pénichon M, Mathieu C, Garrel R, Hillaire-Buys D, Pariente A, Faillie JL. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care. 2023 Feb 1;46(2):384-390. doi: 10.2337/dc22-1148. PMID: 36356111.

Jul 24, 2023 · 3 likes · 11,333 followers View post →
DEMENTORZY
@dementorzy · X

RT @lpietrzak20: Stosowanie analogów GLP-1 (dulaglutydu, liraglutydu, semaglutydu) może zwiększać ryzyko występowania wszystkich nowotworów…

Jul 12, 2023 · 1 share · 3,270 followers View post →
Łukasz Pietrzak
@lpietrzak20 · X

Stosowanie analogów GLP-1 (dulaglutydu, liraglutydu, semaglutydu) może zwiększać ryzyko występowania wszystkich nowotworów tarczycy. https://t.co/b370gefkqS

Jul 11, 2023 · 3 likes · 1 share · 11,053 followers View post →
octonigga ✝️
@ragecoughing · X

@cycl0n3_sw0rd @GOONMEAT_ @DannyJBauer Semaglutide is a GLP-1 receptor agonist and that drug group is linked with increased thyroid cancer. https://t.co/pPZUSar0Af It’s even part of the medication counseling/informed consent any decent medical practitioner needs to discuss with the patient before starting a GLP-1RA.

Jul 10, 2023 · 1 like · 45 followers View post →
Horace Juvenal
@horacejuvenal · X

@tracyktownsend "the effects on humans are unknown" https://t.co/YWtRSkbz6R

Jun 27, 2023 · 1 like · 219 followers View post →
Manuel Rodríguez Rojas
@nonorojas · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer: https://t.co/n0EtW0Ypja https://t.co/9FJSjU47nc https://t.co/HWfxrOGMz9

May 26, 2023 · 271 followers View post →
Zhenqi Liu, MD
@DrZhenqiLiu · X

More data is needed

May 22, 2023 · 2 likes · 880 followers View post →
J Bradley Nelson
@jbradleynelson · X

@ZubyMusic @elonmusk I saw this retro French study abstract in Feb and I got freaked: https://t.co/y5jsKbvBsh

May 12, 2023 · 1 like · 487 followers View post →
Dr.ドクター | 糖尿病専門医Youtuber
@Dr_doctor_DM · X

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390 https://t.co/PD8YqLXMun

May 1, 2023 · 2,831 followers View post →
Dr.ドクター | 糖尿病専門医Youtuber
@Dr_doctor_DM · X

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390 https://t.co/RRrKZFUo7C

May 1, 2023 · 2,831 followers View post →
Dr.ドクター | 糖尿病専門医Youtuber
@Dr_doctor_DM · X

Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:3… https://t.co/jmTTFRooim

May 1, 2023 · 2,831 followers View post →
Dr.ドクター | 糖尿病専門医Youtuber
@Dr_doctor_DM · X

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390 https://t.co/ePB13b6wsM

May 1, 2023 · 2,831 followers View post →
Wearable Wellness Health And Happiness
@LPetcu1 · X

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390 https://t.co/F3pp7A9XCb https://t.co/r1QjPLk6u9

Apr 27, 2023 · 1 like · 48 followers View post →
Diabetes
@Bainein · X

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390 https://t.co/5GNGhIukuP

Apr 27, 2023 · 1 like · 576 followers View post →
Diabetic Guru
@diabetic_guru · X

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390 https://t.co/Pr4YmjyjVH https://t.co/UsEwerSAVT

Apr 27, 2023 · 1 like · 12 followers View post →
SID Italia
@Sid_Italia · X

Journal Club SID GLP-1 e tiroide: nemici o amici? - A cura di Maurizio Di Marco e Federica Vinciguerra https://t.co/AS8x3p2zzt

Apr 7, 2023 · 4 likes · 568 followers View post →
Jean P. Buteau
@JPButeauT · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 19, 2023 · 17 shares · 194 followers View post →
Kelly Naranjo S.
@Kelly_med19 · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 19, 2023 · 17 shares · 165 followers View post →
HUGO COLOMBO MD
@HCOLOMBO1958 · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 17 shares · 1,120 followers View post →
Hugo Fabre MD
@drhfabrem · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 17 shares · 10,596 followers View post →
Eder Andrés
@ederandres152 · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 17 shares · 925 followers View post →
TTPD
@krswift95 · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 17 shares · 2,528 followers View post →
Paris Lavi
@PaLP1924 · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 17 shares · 92 followers View post →
RIM
@Ricardoscientia · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 17 shares · 921 followers View post →
Diego
@Drdiegogastro · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 17 shares · 179 followers View post →
Christian Rodríguez
@ChristianRodCe · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 17 shares · 181 followers View post →
diego pachon
@dpachon29 · X

RT @IlindelatorreMD: Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 17 shares · 7,753 followers View post →
Dr. Ilin Gilberto de la Torre M.
@IlindelatorreMD · X

Agonistas del receptor GLP-1 y el riesgo de cáncer de tiroides. https://t.co/O5mVQ9UDum https://t.co/fDBoXPkKTv

Mar 18, 2023 · 46 likes · 17 shares · 45,732 followers View post →
Lola Monleon
@MonleonLola · X

RT @agingdoc1: GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/TrTfHYlWu6 https://t.co/OyJbjjhy7g

Mar 18, 2023 · 2 shares · 136 followers View post →
Mind Your Science!
@MindYourSci · X

RT @agingdoc1: GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/TrTfHYlWu6 https://t.co/OyJbjjhy7g

Mar 18, 2023 · 2 shares · 132 followers View post →
Agingdoc
@agingdoc1 · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/TrTfHYlWu6 https://t.co/OyJbjjhy7g

Mar 18, 2023 · 6 likes · 2 shares · 42,409 followers View post →
Lead By Example - Level Up Your Life
@JonHenningsen · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/yJ2AHiLnyq

Mar 14, 2023 · 265 followers View post →
Vyvyane Loh, MD
@VyvyaneLohmd · X

Posting this because I hear so many people "wondering" if there are increased risks of thyroid cancer in humans with GLP1 agonists like Ozempic. Yes: https://t.co/G7ovPMlqVL #reversedisease #metabolichealth #Olympic #glp1

Mar 12, 2023 · 6 likes · 380 followers View post →
0000007
@0000007c · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/YAa5TDlekJ

Feb 9, 2023 · 27 followers View post →
リオールジム / 医師推奨のパーソナルジム
@koki_fitness · X

RT @koki_fitness: 劇的なダイエット効果が期待できる、ダイエット薬で甲状腺がんのリスクが上がるかもしれないというデータがアメリカ糖尿病学会の雑誌に掲載 ダイエット薬は劇的な効果が高い一方で、服薬を止めたらリバウンドするなどのデメリットもあります https:…

Jan 28, 2023 · 1 share · 2,065 followers View post →
リオールジム / 医師推奨のパーソナルジム
@koki_fitness · X

劇的なダイエット効果が期待できる、ダイエット薬で甲状腺がんのリスクが上がるかもしれないというデータがアメリカ糖尿病学会の雑誌に掲載 ダイエット薬は劇的な効果が高い一方で、服薬を止めたらリバウンドするなどのデメリットもあります https://t.co/w9TuxLN4Lr

Jan 25, 2023 · 2 likes · 1 share · 2,065 followers View post →
Daniel Martín
@DaniMartinENDO · X

RT @LiebertPub: GLP-1 Receptor Agonists and the Risk of Thyroid Cancer A new study in @clinicalthyroid adds important insight from real-wo…

Jan 25, 2023 · 4 shares · 107 followers View post →
Juan Diego Palacios
@jdpalaciosMD · X

RT @LiebertPub: GLP-1 Receptor Agonists and the Risk of Thyroid Cancer A new study in @clinicalthyroid adds important insight from real-wo…

Jan 25, 2023 · 4 shares · 148 followers View post →
BPCorral
@CorralBp · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer | Clinical Thyroidology https://t.co/vCBdQY8U5P

Jan 25, 2023 · 1 like · 313 followers View post →
Clinical Thyroidology
@clinicalthyroid · X

RT @LiebertPub: GLP-1 Receptor Agonists and the Risk of Thyroid Cancer A new study in @clinicalthyroid adds important insight from real-wo…

Jan 25, 2023 · 4 shares · 8,015 followers View post →
Mary Ann Liebert Inc
@LiebertPub · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer A new study in @clinicalthyroid adds important insight from real-world practice on the potential link of #GLP1 receptor agonists with #thyroidcancer: https://t.co/0Tz8rfRord https://t.co/4QVJSCFOuQ

Jan 25, 2023 · 3 likes · 4 shares · 4,777 followers View post →
Bella Smith
@Bella1847235 · X

@scottisaacsmd @DanielJDrucker Thoughts? https://t.co/ehKIjrPeIP

Jan 24, 2023 · 12 followers View post →
Frank Anthony | Peak Performance
@Frankanthony_ · X

@SamirTabar @Rob_NBF https://t.co/xU5if3gK6H https://t.co/pCYtdIyC9B

Jan 19, 2023 · 1 like · 1,288 followers View post →
Vyvyane Loh, MD
@VyvyaneLohmd · X

@nachX @Steelermilltown @nicknorwitz True. And humans: https://t.co/E8tbsKFKrV

Jan 18, 2023 · 1 like · 380 followers View post →
alephh
@alephh · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer – Use of #GLP1 RA for 1–3 years was associated with increased risk of all thyroid cancer (adjusted hazard ratio a-HR=1.58; 1.27–1.95) and medullary thyroid cancer (adjusted HR=1.78; 1.04–3.05). https://t.co/Qlmc2G98cX https://t.co/mx9CHXZAwd

Jan 17, 2023 · 388 followers View post →
JORGE MORELO
@mmorelo1 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 5, 2023 · 39 shares · 86 followers View post →
Elcy D
@DuarteElcy · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 634 followers View post →
Monica Camargo
@monicamcas · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 227 followers View post →
Maria Maria
@Maria05241306 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 2,946 followers View post →
Rescata
@CarmenZR04 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 2,955 followers View post →
alicia mabel gimenez
@aliciamabelgim1 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 324 followers View post →
samipuan
@samipuan · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 681 followers View post →
MercyRamirez.odonto
@mercyfabiolar2 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 3,122 followers View post →
FREDY QUINTERO
@FREDYQUINTERO8 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 70 followers View post →
Casa de la Ciencia y el Juego. Pasto.
@cevibe5 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 539 followers View post →
Humberto Rodriguez
@humbertro2957 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 3,827 followers View post →
Patricia SH
@patisua131 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 176 followers View post →
Freddy Sanmiguel Chavarriaga
@samto8606 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 197 followers View post →
Jose Matute Gimenez
@JoseMatuteGimen · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 1,020 followers View post →
Hans Castorp
@StevenVinazco · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 66 followers View post →
Giomar Urbina
@GiomarUrbina · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 36 followers View post →
Lau
@HappyPillsL · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 286 followers View post →
Samuel Miranda
@sammiranda1418 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 314 followers View post →
JV
@Reykato · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 131 followers View post →
TITA
@TitarraGuajardo · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 4, 2023 · 39 shares · 1,703 followers View post →
Dr Gando Fisherman
@gandhy_salgado · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 9,468 followers View post →
Maria
@Maria79582549 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 996 followers View post →
adelaida gutierrez
@08Adelaida · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 60 followers View post →
DaniReuma
@dani_reuma · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 363 followers View post →
Juan Daniel C.
@Juancho1789 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 352 followers View post →
Libardo Rios Usuga
@UsugaRios · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 4,439 followers View post →
Ely Cepeda
@elycepedad · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 638 followers View post →
Oscar alberto Rodríguez Álvarez
@Oscaral18537190 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 104 followers View post →
fausto heredia z.
@drfherediaz · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 4,373 followers View post →
Yes31
@yaeko_31 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 2 followers View post →
Edinson Daza Irreño
@DazaIrreno · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 426 followers View post →
Diego San ⚠️
@diego_84 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 1,539 followers View post →
DAMA DE LOS NADIE
@miquimo61 · X

RT @endocrinorosero: Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 39 shares · 1,743 followers View post →
endocrinorosero
@endocrinorosero · X

Dos noticias que a los endocrinos nos tienen rascando la cabeza :

Jan 3, 2023 · 224 likes · 39 shares · 160,102 followers View post →
Sharminder Dr
@kaurSharminder · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 30, 2022 · 33 shares · 27 followers View post →
Ruben Dario Aguirre MD
@Rubencho80 · X

Nada es inocuo y nada supera el ejercicio

Dec 30, 2022 · 1 like · 267 followers View post →
Saúl Sánchez
@SaulNutri · X

Dec 30, 2022 · 1 like · 108,045 followers View post →
Dr. Hugo Corrales - Endocrinología.
@hugoendocrino · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 29, 2022 · 33 shares · 6,471 followers View post →
Dr G.Sudha
@g_ophthalmology · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 29, 2022 · 33 shares · 159 followers View post →
Carolina PCastañeda
@CarolinaPeC · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 29, 2022 · 33 shares · 302 followers View post →
Antonio M Martínez B
@AntonioMTZ96 · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 29, 2022 · 33 shares · 638 followers View post →
Dr.V.Mohan
@drmohanv · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 29, 2022 · 33 shares · 129,499 followers View post →
Ermias
@Ermiafar1098 · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 29, 2022 · 33 shares · 25 followers View post →
Dr. Rajesh Jain, MD
@DiabetesAsiaOrg · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 29, 2022 · 33 shares · 1,674 followers View post →
Ali Aminian
@Ali_Aminian_MD · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 7,957 followers View post →
Doç.Dr. Savaş Karataş
@SAVASKARATAS · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 227 followers View post →
Leonardo
@1EnGiRe · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 90 followers View post →
artem morozov
@artemmo30776735 · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 25 followers View post →
Marcelo González Guzmán
@MarceloGonzalez · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 2,123 followers View post →
Dr. Shashank Joshi
@AskDrShashank · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 32,580 followers View post →
د.عبدالعزيز الفضلي
@dr_azouz · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 2,447 followers View post →
Dr. Afzal Haq Asif
@Dr_AfzalHaqAsif · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer | Diabetes Care | American Diabetes Association https://t.co/5GIxZ9LWa4

Dec 28, 2022 · 1 like · 749 followers View post →
Alshaimaa Abdelghani
@alshaimaaabdelg · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 183 followers View post →
Dr Ruth Tapsell
@RuthTapsell · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 2,346 followers View post →
ALPHONCE OYUGI
@OyugiOyugi2 · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 299 followers View post →
ADA Professional Publications
@ADA_Pubs · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 10,631 followers View post →
Kunal Jha MD
@kunaljhamd · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 592 followers View post →
Diabetes Care, a research journal of the ADA
@DiabetesCareADA · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 3,191 followers View post →
Afnan Alshnbari
@afnan_sj1 · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 428 followers View post →
John Hayes Jr MD
@NeuropathyDoc · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 6,904 followers View post →
Clinical Neuroendocrinology Basel
@ClinNeuroEndo · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/vIrPfPsOe7

Dec 28, 2022 · 1 like · 471 followers View post →
Abdulmohsen bakhsh د .عبدالمحسن بخش
@amohsenbakhsh · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 2,022 followers View post →
TBH
@TBH_Healthcare · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 159 followers View post →
Joel Bravo
@joelbravoes · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 37 followers View post →
Rajiv Dhir
@rajiv_dhir2 · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 28, 2022 · 33 shares · 122 followers View post →
AN
@aamirna40591785 · X

RT @docmaltese: GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhm…

Dec 27, 2022 · 33 shares · 27 followers View post →
Giuseppe Maltese
@docmaltese · X

GLP-1 receptor agonists and risk of thyroid cancer -via @DiabetesCareADA @XarisKoufakis @DrMohgah @cristinatejerap @tejhmal https://t.co/73VNByrOLY https://t.co/Ngb6ObhcS5

Dec 27, 2022 · 103 likes · 33 shares · 1,787 followers View post →
Álvaro Jeria
@aijeria · X

Ojo pues hay información clara del aumento de riesgo de cáncer en humanos! Sugiero revisar este paper https://t.co/98bDfoFmvh Y SIEMPRE consultar con su médico antes de tomar decisiones sobre su salud, sobre todo si implica administrar medicamentos!! https://t.co/PZKB1hoWo0

Dec 21, 2022 · 4 likes · 4,365 followers View post →
Alex Kravetz
@adkravetz · X

@DanielJDrucker Hey Daniel, curious to get your thoughts on the recently published French retrospective study on thyroid cancer in GLP1RA therapy (HR: 1.58) https://t.co/d89MiIRqou

Dec 19, 2022 · 734 followers View post →
Ayo B
@ayoIB · X

I'm going to start including TFTs and thyroid history as part of my baseline and routine monitoring. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/5vHdteP0ax

Dec 16, 2022 · 176 followers View post →
Justin
@jzelenk · X

@EricTopol Thank you for putting this together. I do wonder about the theoretical risk of thyroid cancer seen in preclinical studies. This recent population based study suggests more defined monitoring might be helpful. https://t.co/A7MTGuGfWp

Dec 15, 2022 · 1 like · 159 followers View post →
R Giovanni Diaz-Zavala
@DrGiovanniD · X

RT @AdrianSotoMota: @DrGiovanniD Y esa seguridad a largo plazo sigue en estudio. https://t.co/gHNW0m1bPw

Dec 14, 2022 · 1 share · 16,007 followers View post →
Adrian Soto-Mota
@AdrianSotoMota · X

@DrGiovanniD Y esa seguridad a largo plazo sigue en estudio. https://t.co/gHNW0m1bPw

Dec 14, 2022 · 2 likes · 1 share · 9,208 followers View post →
Jonathan D. Halevi
@jdhalevi · X

@IdoWolf1 "In the current study we found increased risk of all thyroid cancer and medullary thyroid cancer with use of GLP-1 RA, in particular after 1–3 years of treatment" https://t.co/mqD8H3Bz5E

Dec 11, 2022 · 1 like · 8,077 followers View post →
David León Jiménez
@drleonjimenez · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/0ztFYxzQaB OJO

Dec 9, 2022 · 1,120 followers View post →
Beverly G. Tchang, MD
@BevTchangMD · X

Ref: https://t.co/qNuWUXcuff

Dec 9, 2022 · 4 likes · 6,239 followers View post →
Mercedes Codina
@codinamar · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/TucaMliVJQ

Dec 9, 2022 · 853 followers View post →
Alberto Dias Filho
@albertodiasf · X

https://t.co/r9mEpjcFdv

Dec 7, 2022 · 234 followers View post →
Helper1 (blue checkmark)
@helper409 · X

@AviBittMD A pill for an ill With a side risk of cancer. What could possibly go wrong. I’m sure the high profit margins have nothing to do with any of this https://t.co/LvLTQOnmzP.

Dec 5, 2022 · 14 followers View post →
Rosa María Sanchez Hernández
@RosaMar80096461 · X

RT @JorRuizSanchez: ¿Quién ha leído el impactante artículo del DiabetesCare ? https://t.co/Ex1NWpx3Y2 Hay que leerlo con cuidado, y por es…

Dec 4, 2022 · 51 shares · 10 followers View post →
j..
@josue_ · X

RT @BebaVegaN: https://t.co/35lW93AgTw Ojo c/ partir tto sin supervición médica, hay pctes q comparten datos d fármacos sin evaluar los ri…

Dec 2, 2022 · 2 shares · 95 followers View post →
Diabetes Care, a research journal of the ADA
@DiabetesCareADA · X

RT @BebaVegaN: https://t.co/35lW93AgTw Ojo c/ partir tto sin supervición médica, hay pctes q comparten datos d fármacos sin evaluar los ri…

Dec 1, 2022 · 2 shares · 3,191 followers View post →
Vanessa vega
@BebaVegaN · X

https://t.co/35lW93AgTw Ojo c/ partir tto sin supervición médica, hay pctes q comparten datos d fármacos sin evaluar los riesgos d éstos. Dejo dato de Ozempic y riesgo de cáncer de tiroides. Sólo puedes usarlo bajo indicación médica! #cancerdetiroides #MinuevoYo #Ozempic https://t.co/TkflGjeu6E https://t.co/iuGu4gBny8

Dec 1, 2022 · 3 likes · 2 shares · 526 followers View post →
jojo
@Joory20153 · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 29, 2022 · 17 shares · 4 followers View post →
Abdulaziz Alqahtani
@A_alqahtani014 · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 29, 2022 · 17 shares · 1,591 followers View post →
Vargas-Vazquez A
@VargasVazquezA1 · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 27, 2022 · 17 shares · 63 followers View post →
Yiannis Zachariades
@yianniszacharia · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 26, 2022 · 17 shares · 875 followers View post →
Colorful MD Phd
@FanYang38636272 · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 26, 2022 · 17 shares · 58 followers View post →
LeonardH
@OSheaLaos · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 26, 2022 · 17 shares · 429 followers View post →
Josep M Mercader
@josep_mercader · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 25, 2022 · 17 shares · 553 followers View post →
Valnet Rabier Marie Blanche
@MarieBlancheVR · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 25, 2022 · 17 shares · 99 followers View post →
Jean-Luc Faillie
@jlfaillie · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 25, 2022 · 17 shares · 274 followers View post →
DiabetoPitie
@DiabetoPitie · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 25, 2022 · 17 shares · 290 followers View post →
AllaShepelkevich
@AllaShepelkevi1 · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 25, 2022 · 17 shares · 100 followers View post →
Zaheer Bayat
@ZaheerBayat786 · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 24, 2022 · 17 shares · 282 followers View post →
RONAK GANDHI
@drronakmgandhi · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 24, 2022 · 17 shares · 260 followers View post →
ADA Professional Publications
@ADA_Pubs · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 24, 2022 · 17 shares · 10,631 followers View post →
j..
@josue_ · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 24, 2022 · 17 shares · 95 followers View post →
j_bezin
@j_bezin · X

RT @DiabetesCareADA: A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased r…

Nov 24, 2022 · 17 shares · 152 followers View post →
Diabetes Care, a research journal of the ADA
@DiabetesCareADA · X

A nationwide population-based study suggests that the use of GLP-1 receptor agonists is associated with an increased risk of thyroid cancer. #Pharmacoepi @DrugsSafe Read Here➡️https://t.co/s0PAaHPbq5 https://t.co/JOOd98Yo8i

Nov 24, 2022 · 39 likes · 17 shares · 3,191 followers View post →
Luis Tobajas Belvís
@luisotobajas · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer https://t.co/sgUNKawHj2

Nov 19, 2022 · 8,756 followers View post →
Arti Bhan
@ArtiBhan1 · X

https://t.co/8nQ9d9Sq4c

Nov 16, 2022 · 3 likes · 2,296 followers View post →
Alberto Dias Filho
@albertodiasf · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer | Diabetes Care | American Diabetes Association https://t.co/r9mEpjugC5

Nov 15, 2022 · 1 like · 234 followers View post →
小人の妖精
@gUurQgHfVZAC0n1 · X

RT @akkiii0830: GLP-1 Receptor Agonists and the Risk of Thyroid Cancer | Diabetes Care | American Diabetes Association https://t.co/9K1ZrcW…

Nov 15, 2022 · 1 share · 573 followers View post →
名前
@akkiii0830 · X

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer | Diabetes Care | American Diabetes Association https://t.co/9K1ZrcWzkz

Nov 15, 2022 · 2 likes · 1 share · 245 followers View post →
pinacol
@pinacol · X

【コホート内症例対照研究】2次治療の抗糖尿病薬で治療されている2型糖尿病患者において、1-3年のGLP-1RAの使用は甲状腺癌のリスク増加と関連した。 #ペ読 https://t.co/ksupZYiPma

Nov 12, 2022 · 3 likes · 1,620 followers View post →